News | Stem Cell Therapies | August 04, 2017

New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks

Research team hopes growing and observing colonies of cardiac cells will offer new insight into how the heart repairs itself after injury

New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks

August 4, 2017 — In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of cardiac cells, formed into chambers, that pump and contract like a human heart. Derived from stem cells, these primitive organs will help her achieve a research milestone: to observe in microscopic, real-time detail how the heart repairs itself after injury.

She must first induce an “attack” by damaging the tiny proto-hearts with a frozen rod, thus mobilizing sequential, cell-based repair crews that clear the injury site of debris, and then in a second phase, recruit materials and tools from the neighboring tissue to mend the damage.

“By developing diseased-tissue models, we’re hoping to gain insights that will allow us to improve diagnoses and therapies for cardiac diseases,” said Lee, an assistant professor of biomedical engineering. “These are techniques that cannot be tested in patients.”

Earlier in 2017, she received a five-year Faculty Early Career Development (CAREER) Award from the National Science Foundation (NSF) to advance understanding of the underlying mechanisms of heart tissue repair by cell-based therapy. NSF CAREER awards, described by the agency as among its most prestigious, are highly selective grants that support early-career researchers with “the potential to serve as academic role models in research and education and to lead advances in the mission of their department or organization.”

In awarding her the grant, the NSF acknowledged “major hurdles” to date in developing cell-based therapies – restoring damaged tissue by deploying transplanted stem cells to the injury site – that derive in part from limited knowledge of the biological mechanisms of the transplanted cells. Existing models have focused almost exclusively on mimicking the healthy cardiac microenvironment with the goal of providing a living surgical replacement. In order to develop alternative therapies, the agency deems her model both novel and necessary.

“What is unique about these experiments is the opportunity they provide to see how different cell types in the heart interact during the repair process in the immediate aftermath of a heart attack – the period that offers the best chance for successful cell-therapy interventions,” Lee noted. “Better understanding of diseased tissue can help us to predict how stem cells used in cell-based therapy will integrate and function in the body.”

Medical researchers have had little success with these therapies so far, because the injected cells drift away from the injury and fail in their task to rebuild tissue. “They don’t stick to the site, and eventually they die,” Lee said.

Unlike most biological tissues, heart cells do not regenerate or proliferate. Following injury, the damaged tissue is not so much restored as slightly reconfigured. It becomes stiffer and less functional.

Lee is focusing on the first two stages of repair: an initial phase of about seven days during which the body sends out macrophages — inflammatory cells that clear the site by engulfing and consuming the destroyed tissue — followed by a weeks-long proliferation phase, in which cardiac fibroblast cells (connective cells) become activated and migrate to the region of dead tissue to synthesize new extracellular matrix – the structural molecules that support heart cells – and remodel the tissue.

“We’re trying to figure out what biological mechanisms will guide the stem cells used in therapy to the right place and foster their growth there,” Lee explained. She and Pamela Hitscherich, a Ph.D. student in her laboratory, are testing various scenarios in which the heart cells – cardiomyocytes – interact in different sequences with the inflammatory repair cells.

A crucial element of this process is ensuring there are enough blood vessels to supply the tissue with the nutrients and energy it needs to grow.

“In order to build what’s physiologically correct, we must incorporate vasculature, a functioning network of vessels to feed the new organ cells and permit their growth, and we are still searching for the best strategy to create this tissue,” she said. “It’s difficult to do outside of the body without proper blood flow and signals from other cells and tissues.” She is currently investigating the role of tissue-specific vascular cells and improving a device she created to host vessel-formation experiments.

Lee said it has been difficult to fully understand the healing process because of the body’s complexity.

“In the case of a heart attack, a series of events, including inflammation, proliferation and remodeling, occur at the damaged heart region,” she explained. “That’s why the in vitro model is critical. It’s a simplified set-up that allows us to study different parameters independently and tease out the problem.”

“We want to know, for example, what components in heart tissue prompt the stem cells to adhere and when is the best time to inject them,” she added. “We can also develop newer therapeutic interventions to help these stem cells home in and ultimately restore the heart function.”


Related Content About Stem Cell Therapies to Restore Heart Function

FDA Says Adult Stem Cell Research Shows Promise

Stem Cell Therapy Holds Promise for Treating Most Severe Cases of Angina

3-D Printed Patch Can Help Mend "Broken" Heart

Cardiac Regeneration After MI: Role of the Extracellular Matrix

Post Heart Attack Recovery Not Aided By Stem Cell Injections, But Demonstrates Promise

Resurrecting Dead Heart Tissue

For more information:

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics | December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics | November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics | November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics | October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
Overlay Init